Stanford researchers have patented an image sensor that overcomes frame rate and power consumption limits for high-speed mega-pixel imaging, and therefore can extend battery life for mobile phone cameras.
A team of researchers at Stanford have developed a hydrogel that delivers a scar-reducing focal adhesion kinase inhibitor (FAK-I) to skin grafts and donor sites.
Stanford inventors have discovered that applying a hydrogel containing an inhibitor of mechanotransduction pathways on top of a skin graft reduces scarring and promotes healing after repair of traumatic injuries like severe burn wounds.
Stanford researchers have developed a strategy for secondary wastewater treatment using a membrane-aerated biofilm reactor (MABR) design that enables the simultaneous removal of pollutants and recovery of potent greenhouse gas (N2O) emissions.
Stanford researchers have developed a targeted antisense oligonucleotide (ASO) therapy to selectively reduce the expression of NaV1.7, a key sodium channel implicated in chronic pain signaling.
Stanford researchers have patented a silicon germanium (SiGe) electroabsorption modulator that can operate well in excess of 10 Gbps and is entirely compatible with Silicon (Si) complementary metal-oxide semiconductor (CMOS) integrated circuit fabrication.
Researchers in the laboratories of Prof. Stanley Cohen and Prof Tzu-Hao Cheng have discovered that Supt4h is a potential therapeutic target for reducing toxicity and restoring the functionality of deleterious proteins in Huntington's (HD) and other polyQ diseases.
Stanford researchers have designed a high-voltage cascode GaN/SiC device combining the advantages of both a GaN and an SiC device (i.e. reduced gate loss/simple gate drive requirements)
Stanford researchers in the WE3 and S3 Labs developed a cloud-based computation and predictive control platform for wastewater treatment facilities energy storage and energy generation. Wastewater treatment is energy and cost intensive.
Stanford researchers have developed a novel electrode composed of copper-based catalyst and a carbon-based catalyst to directly convert CO2 into ethylene, a valuable carbon-based molecule.
To manage the development and progression of glaucoma, researchers at Stanford University have developed a biocompatible suprachoroidal spacer implant.
Light with a narrowband spectrum is launched into the FBG, at a wavelength located on one of the two edges of the reflection peak of the FBG, i.e., at a wavelength where the FBG transmits, rather than reflects, light.
Stanford researchers have recently patented a hybrid LED-LCD screen suitable for applications ranging from large televisions to small mobile displays and capable of significantly reducing power consumption to as little as 1/20th that of conventional design